Acorda Therapeutics (ACOR) Tops Q1 EPS by 18c
Get Alerts ACOR Hot Sheet
Price: $0.66 --0%
Revenue Growth %: +63.1%
Financial Fact:
Interest income: 46K
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: +63.1%
Financial Fact:
Interest income: 46K
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q1 EPS of $0.36, $0.18 better than the analyst estimate of $0.18. Revenue for the quarter came in at $71.25 million versus the consensus estimate of $70.95 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!